Pfizer-Wyeth in Canada
January 26, 2009
Posted by on
Following today’s developments, some Canadian stats from the Pfizer Canada and Wyeth Canada web sites:
Pfizer employs more than 1,400 Canadians, including more then 1,200 in Pfizer Global Pharmaceuticals, 100 in Pfizer Animal Health and 100 in our distribution centers. Pfizer opened its first Canadian operations in 1953 in Montreal, Quebec. The Pharmaceutical and Animal Health businesses are based in Kirkland, Quebec.
Current Canadian facilities include the following:
- Kirkland, Quebec – Canadian headquarters, Pfizer Global Pharmaceuticals and Pfizer Animal Health
- Calgary, Alberta – Distribution Centre, Pfizer Animal Health
- Mississauga – Logistics Center
As one of the top corporate donors in Canada, Pfizer Canada is a proud member of Imagine Canada and its Caring Company program. In 2006, Pfizer Canada’s Community Investment Program supported more than 1,000 non-profit organizations across the country with a total investment of $20 million. Pfizer Canada is the top contributor to Health Partners International of Canada (HPIC). Since 1994, Pfizer Canada has donated more than $35.4 million essential medicines to HPIC for the developing world.
Wyeth Canada’s research and development activities in Montreal include a state-of-the-art facility with 245 employees working in either the Clinical Research and Development centre, Clinical Supply division, Chemical Development division, or various support groups.
Wyeth Canada employs more than 1,900Canadians in various divisions of the Company, including Wyeth Pharmaceuticals, Wyeth Consumer Healthcare, Wyeth Animal Health, Wyeth Research, and Wyeth Organics.
In 2005, Wyeth Canada invested $64.5 million (CDN) in R&D in Canada—an increase of 83% since the year 2000.
Wyeth Canada has supported 4 Clinical Research Chairs in Women’s Health. Continuing our strong support of excellence in research, Wyeth Canada currently supports two Clinical Research Chairs in Vaccines, and four Clinical Research Chairs in Transplantation. Each Chair is worth a total of $1.1 million over five years and are co-funded by Wyeth Canada, the Canadian Institute of Health Research (CIHR)/Rx&D Research Program and the recipient’s university. In 2007, new Clinical Research Chairs will be established in Oncology and in Transplantation.
Wyeth Canada funds two-year Post-Doctorate Fellowships in partnership with the CIHR. Each year, 10 new programs are introduced in several therapeutic areas for researchers in universities across the country.
Wyeth Canada’s Care Until Cure Research Program is the largest grant of its kind managed by the Canadian Hemophilia Society. This program, established in 2000, provides annual grants to Canadian investigators that allow Canadian investigators to conduct research on various medical and psychosocial aspects of bleeding disorders.